Scheme

DSP Nifty Healthcare ETF

Holds 20 companies worth ₹17 Cr in Sept 2026.

Fund house
DSPThe fund house that runs this scheme.
AUM
₹17.1 CrDSP Nifty Healthcare ETF's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 5.9% on Aug 2026, ₹18.1 Cr.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 17.0% of this scheme's NAV.
Fund manager
Anil GhelaniRuns it since 1 Feb 2024, as the fund house dates it. With Diipesh Shah (co-manager), Neha Rathi (co-manager).

Holdings^{(Feb 2024 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	20 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	2.9
	Divi s Laboratories Limited	1.8
	Apollo Hospitals Enterprise Limited	1.3
	Laurus Labs Limited	1.2
	Cipla	1.1
	Dr Reddy s Laboratories Limited	1.1
	Torrent Pharmaceuticals Limited	1.1
	Max Healthcare Institute Limited	1
	Lupin	0.74
	Aurobindo Pharma	0.7
	Fortis Healthcare Limited	0.6
	Glenmark Pharmaceuticals	0.53
	Alkem Laboratories Limited	0.47
	Cadila Healthcare	0.43
	Mankind Pharma Limited	0.43
	IPCA Laboratories Limited	0.4
	Biocon	0.39
	Gland Pharma Limited	0.35
	Krishna Institute of Medical Science Ltd	0.3
	Abbott India Limited	0.21

Fig. 1.Market value of each ticked company in DSP Nifty Healthcare ETF, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	16K	2.9	16.99
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	1.92K	1.8	10.43
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	1.55K	1.3	7.42
Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	5.87K	1.2	6.81
Cipla	Equity	Pharmaceuticals & Biotechnology	8.48K	1.1	6.69
Dr Reddy s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	9.19K	1.1	6.64
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	2.22K	1.1	6.24
Max Healthcare Institute Limited	Equity	Healthcare Services	11.2K	1	6.11
Lupin	Equity	Pharmaceuticals & Biotechnology	3.66K	0.74	4.36
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	4.16K	0.7	4.08
Fortis Healthcare Limited	Equity	Healthcare Services	7.85K	0.6	3.54
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	2.27K	0.53	3.11
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	909	0.47	2.75
Cadila Healthcare	Equity	Pharmaceuticals & Biotechnology	3.73K	0.43	2.54
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	1.71K	0.43	2.51
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	2.09K	0.4	2.36
Biocon	Equity	Pharmaceuticals & Biotechnology	10.5K	0.39	2.28
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	1.2K	0.35	2.04
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	4.02K	0.3	1.76
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	79	0.21	1.26

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.